Unknown

Dataset Information

0

Immunotherapy for MIS-C - IVIG, Glucocorticoids, and Biologics.

ABSTRACT:

SUBMITTER: DeBiasi RL 

PROVIDER: S-EPMC8362545 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Immunotherapy for MIS-C - IVIG, Glucocorticoids, and Biologics.

DeBiasi Roberta L RL  

The New England journal of medicine 20210616 1

Similar Datasets

Unknown Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty: A Cohort Study.
| S-EPMC7197029 | biostudies-literature
Genomics IVIg
| PRJEB44531 | ENA
Unknown Understanding the Targeting Mechanisms of Multi-Specific Biologics in Immunotherapy with Multiscale Modeling.
| S-EPMC7710644 | biostudies-literature
Unknown Therapeutic Window of Intravenous Immunoglobulin (IVIG) and its correlation with IVIG-resistant in Kawasaki Disease: a retrospective study.
| S-EPMC10031361 | biostudies-literature
Unknown IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP.
| S-EPMC7160294 | biostudies-literature
Unknown Intravenous Immunoglobulin G (IVIG) Need Assessment Survey Toward Local Manufacturing of IVIG Using a Mini-Pool Plasma Fractionation Technique
| S-EPMC9969427 | biostudies-literature
Unknown IgG Glyco-Engineering to Improve IVIg Potency.
| S-EPMC6206079 | biostudies-literature
Unknown Biologics in dermatology.
| S-EPMC3816698 | biostudies-literature
Unknown Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial.
| S-EPMC8177439 | biostudies-literature
Unknown Glucocorticoids and Cancer.
| S-EPMC5546099 | biostudies-literature